PFSA Stock Whipsaws As Traders Track Extreme Volatility

Profusa Inc. surged as stocks have been trading up by 75.47 percent amid heightened optimism around its biomedical innovations.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PFSA

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

PFSA has slid from late-August highs near $3.55 into the low $2s, signaling a sharp pullback after a strong run.
Intraday trading in Profusa Inc. shows violent swings from $2 to above $4.50, highlighting aggressive day-trader activity.
PFSA financials reveal heavy losses, negative equity, and high liabilities, putting the company firmly in “speculative” territory.
Cash flow data shows Profusa Inc. burning cash and relying on fresh debt, a major risk that active traders must respect.
Technical levels around $2 and the recent $4 spike zone are key battlegrounds PFSA traders are watching.

Live Update At 09:20:04 EDT: On Thursday, September 24, 2026 Profusa Inc. stock [NASDAQ: PFSA] is trending up by 75.47%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Profusa Inc., trading as PFSA, is the definition of a speculative small-cap. The balance sheet is upside down. PFSA shows about $1.0M in total assets against roughly $28.2M in total liabilities, leaving stockholders’ equity at around -$27.1M. That negative equity tells traders the company owes far more than it owns.

On the income side, PFSA reported about -$8.8M in net income for the latest quarter, with an operating loss near -$2.5M and a very large hit from non-operating items. Basic and diluted earnings per share come in around -$151.80, an extreme number driven by the tiny share count and deep losses. For traders, it’s a clear sign this is not a steady, cash-generating business.

More Breaking News

Cash flow paints the same picture. PFSA posted roughly -$2.6M in operating cash flow and about -$2.7M in free cash flow, while cash at period end was only about $719,000. That gap is being plugged with debt — about $3.0M in net debt issuance. In plain terms, Profusa Inc. needs outside money to keep going. When traders see PFSA, they’re not paying for strong fundamentals. They’re paying for volatility and the chance of a short-lived spike.

Why Traders Are Watching PFSA’s Wild Price Swings

PFSA has turned into a pure trading vehicle. On the daily chart, Profusa Inc. ran from about $2.55 on 2026/08/31 to a high of $3.55 that day, then failed to hold those levels. Since then, PFSA has kept grinding lower, with closes slipping from $3 to the low $2s. The recent close around $2.05 marks a significant drawdown from that late-August push.

What draws traders in is the range. PFSA logged multiple sessions with intraday highs near $2.90–$3.00 but often closed well off those peaks. That’s classic “pop and fade” behavior — strong morning momentum followed by heavy profit taking or dilution selling. For short-term trading, those patterns are a gold mine if you time them correctly, and a disaster if you chase late.

The intraday 5‑minute chart shows exactly how violent PFSA can be. Pre-market action jumped from about $2 at 07:30 to a high above $4.49 in minutes, then slammed back into the $3s and $2s before the open. Later candles show repeated runs above $4.20 and $4.50 followed by sharp drops under $3.60. This is the kind of tape where spreads widen, liquidity thins out, and stop losses get hit fast.

Traders watching PFSA should see two clear zones. First, the $2 area on the daily chart — which has acted as a recent pivot and psychological level. Second, the intraday spike zone around $4–$4.50, where momentum blow-offs have stalled. Profusa Inc. doesn’t have the fundamentals to justify a long-term hold, but PFSA clearly has enough crowd attention to produce big, tradeable moves when volume hits.

Conclusion

PFSA is not a stable, blue-chip story; Profusa Inc. is a high-risk, high-volatility ticker built for traders who live and breathe momentum. The fundamentals show a company with negative equity, ongoing losses near the $8.8M level per quarter, and a heavy reliance on fresh debt to fund operations. That’s why traditional value screens will skip PFSA entirely. But for day traders, those same weaknesses often translate into dilution waves, headlines, and sudden spikes that drive volume.

The chart confirms that PFSA is a momentum playground. Big rips toward $4–$4.50, hard reversals into the low $3s, and a broader drift from the $3s back to the $2 zone all tell the same story: no one is in long-term control. Shorts press pops, dip buyers step into panic flushes, and both sides scramble to cover when Profusa Inc. catches a new burst of action.

For traders studying PFSA, risk management comes first. The financials warn that Profusa Inc. has little room for error, and the intraday swings show how fast an undisciplined trade can implode. As Tim Sykes loves to remind his students, “The market doesn’t owe you anything — that’s why you cut losses quickly and let the best setups come to you.” And in the same spirit of staying grounded in real-time price action, as Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” PFSA gives plenty of excitement, but only disciplined trading keeps that excitement from becoming an expensive lesson.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!